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Amphetamines modify the brain and alter behavior
through mechanisms generally attributed to their
ability to regulate extracellular dopamine concentra-
tions. However, the actions of amphetamine are also
linked to adaptations in glutamatergic signaling. We
report here that when amphetamine enters dopa-
mine neurons through the dopamine transporter, it
stimulates endocytosis of an excitatory amino acid
transporter, EAAT3, in dopamine neurons. Consis-
tent with this decrease in surface EAAT3, amphet-
amine potentiates excitatory synaptic responses in
dopamine neurons. We also show that the process
of internalization is dynamin- and Rho-mediated
and requires a unique sequence in the cytosolic C
terminus of EAAT3. Introduction of a peptide based
on this motif into dopamine neurons blocks the
effects of amphetamine on EAAT3 internalization
and its action on excitatory responses. These data
indicate that the internalization of EAAT3 triggered
by amphetamine increases glutamatergic signaling
and thus contributes to the effects of amphetamine
on neurotransmission.
INTRODUCTION
Psychostimulant drugs such as amphetamine (AMPH) and
cocaine are thought to produce their acute behavioral effects
and to activate neuronal pathways that contribute to addic-
tion predominantly through their ability to increase extracellular
dopamine (DA) (Hyman et al., 2006). Although DA itself is clearly
important for these actions, recent work underscores the impor-
tance of changes in glutamatergic signaling after AMPH treat-
ment as well (Reissner and Kalivas, 2010; Wolf and Ferrario,
2010). For example, AMPH increases extracellular glutamate in
various brain regions including the striatum, VTA, and NAc (Del
Arco et al., 1999; Kim et al., 1981; Mora and Porras, 1993; Xue
et al., 1996), but it has not been established whether this change
can be explained by increased synaptic release or by reduced404 Neuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc.clearance of glutamate. In vivo microdialysis studies indicate
that the increases in extracellular glutamate are calcium inde-
pendent (Del Arco et al., 1998, 1999; Xue et al., 1996) suggesting
that synaptic release does not fully account for the observed in-
creases in extracellular glutamate concentrations. A reduction
in glutamate clearance through the changes in glutamate trans-
port activity provides a potential mechanism to explain these
calcium-independent increases in extracellular glutamate after
AMPH treatment.
Sodium-dependent glutamate transporters are the primary
means for clearing synaptic and extrasynaptically released
glutamate in the CNS. There are five distinct isoforms of the
excitatory amino acid transporters (EAATs) responsible for main-
taining extracellular glutamate at concentrations that determine
the temporal and spatial precision of glutamatergic neurotrans-
mission and limit the excitotoxic actions of glutamate. In general,
EAAT1 and EAAT2 are found predominantly in astrocytes,
EAAT3 in neurons, EAAT4 in Purkinje cells, and EAAT5 expres-
sion is restricted to the retina (Danbolt, 2001). We hypothesized
that modulation of a glutamate transporter, particularly the
neuronal EAAT3 subtype present on the soma and processes
of DA neurons, contributes to the increase in extracellular gluta-
mate caused by AMPH.
We report here that AMPH influx through the DA transporter
(DAT) induces endocytosis of EAAT3, the glutamate transporter
subtype in DA neurons. We found that this internalization is
dependent on dynamin and AMPH-mediated activation of a
Rho-GTPase. Further, a unique sequence in the C terminus of
EAAT3 confers sensitivity to AMPH and the introduction of
a peptide comprised of this domain can prevent internalization
of EAAT3, most likely by binding competitively to a regulatory
complex required for AMPH-mediated endocytosis. Trafficking
of EAAT3 from the cell surface after AMPH treatment potentiates
glutamatergic synaptic transmission by reducing glutamate
clearance, demonstrating a mechanism through which AMPH
can regulate the actions of glutamate in the midbrain.
RESULTS
AMPH Decreases EAAT3 Glutamate Uptake in Midbrain
DA Neurons
To examine the effects of AMPH on EAATs in midbrain neurons,
we examined glutamate transport activity in primary midbrain
Figure 1. AMPH Stimulates Internalization
of the Glutamate Transporter EAAT3
(A) Glutamate uptake in primary midbrain cultures
after AMPH treatment. EAAT2-mediated 3H-
glutamate transport (DHK-sensitive, Na+-depen-
dent uptake) was not significantly altered by
AMPH pretreatment (112.2% ± 15% of vehicle-
treated control). The EAAT3-mediated 3H-gluta-
mate transport (DHK-insensitive, Na+-dependent
uptake) in these cultures is mediated by EAAT3
and this component of the glutamate transport
was significantly attenuated by AMPH treatment
(38.4% ± 16%). All data represent mean ± SEM.
(B) Characterization of DA neurons in culture. Neu-
rons in primary midbrain cultures that express tyro-
sine hydroxylase (TH, green) also express DAT and
EAAT3 (red). All DAT(+) cells were also EAAT3(+).
(C) Glutamate uptake in HEK cells transiently
transfected with EAAT1, EAAT2, and EAAT3. HEK
cells transiently expressing DAT with either
EAAT1, EAAT2, or EAAT3were treated with AMPH
(10 mM), or vehicle for 30 min and then 3H-gluta-
mate transport was measured. Only transport
mediated by EAAT3 exhibited sensitivity to AMPH.
*p < 0.05 by two-way ANOVA.
(D) TIRF quantification of EAAT3 internalization EAAT2 or EAAT3 cells treated with vehicle or AMPH were monitored by TIRF. The vehicle-treated traces indicate
that both carriers are relatively stable over this time course in these cultures. EAAT3 surface membrane localization decreased under AMPH conditions while the
EAAT2 protein remained stable.
See also Figure S1.
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Amphetamine-Mediated Internalization of EAAT3cultures. AMPH (10 mM) pretreatment for 30 min decreased total
3H-glutamate uptake in these cultures by 23% ± 9%. There are
several routes for glutamate entry into cells in these cultures
including Na+-dependent EAAT-mediated and Na+-independent
pathways. The Na+-independent component was assessed in
sodium-free (choline-substituted) buffer and was not altered
by AMPH pretreatment. EAAT1 was not detected in cultured
mouse midbrain neurons when assessed by western blot (Fig-
ure S1A available online). Moreover, the EAAT1-specific inhibitor
2-amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(naphthalen-
1-yl)-5-oxo-4H-chromene-3-carbonitrile, UCPH-101 (Jensen
et al., 2009), that selectively blocks EAAT1 uptake in HEK293
cells (Figure S1B), had no effect on Na+-dependent glutamate
uptake in the midbrain cultures indicating that EAAT1 does not
contribute to glutamate transport in these cultures (Figure S1C).
The contribution of EAAT2 to glutamate uptake was deter-
mined using the EAAT2-selective inhibitor di-hydrokainate
(DHK, 100 mM). DHK-sensitive, EAAT2 uptake was not altered
by AMPH (Figure 1A). The remaining glutamate transport in
these midbrain cultures is likely mediated by EAAT3 and this
component was significantly decreased by AMPH (Figure 1A).
EAAT3 expression in these cultures was detected in DAT(+)
and tyrosine hydroxylase(+) cells suggesting that DA neurons
could be the site for AMPH-sensitive EAAT3 modulation
(Figure 1B).
Effects of AMPHwere also determined for HEK293 cells selec-
tively coexpressing EAAT1, EAAT2, or EAAT3 with DAT. Pre-
treatment of the cells with AMPH (10 mM) for 30 min resulted in
a decrease in the transport capacity of EAAT3, whereas EAAT1
and EAAT2 were unaffected (Figure 1C). The Vmax of EAAT3
was diminished by 64% but there was no significant change inthe Km for glutamate (Km vehicle = 57.9 ± 25 mM versus
AMPH-treated = 33.9 ± 33 mM). These data suggest that traf-
ficking of the carrier out of the cell membrane causes the
AMPH-mediated decrease in EAAT3 activity.
Previous work has shown that amphetamines, unlike cocaine
and other nontransported blockers, have the ability to stimulate
internalization of DAT from the cell surface (Lu¨scher and Mal-
enka, 2011; Saunders et al., 2000). We addressed the possibility
that AMPH also stimulated internalization of EAAT3 using total
internal reflection fluorescence (TIRF) microscopy to monitor
trafficking of a tagged eGFP-EAAT3 in HEK293 cells. We
observed a loss of eGFP-EAAT3 fluorescence at the membrane
after AMPH application, but no change in fluorescence in parallel
experiments in eGFP-EAAT2-expressing cells (Figure 1D). These
data suggest that internalization of cell surface EAAT3 may
contribute to the rise in extracellular glutamate observed
following AMPH administration.
AMPH Induces Trafficking of Endogenous EAAT3 in
Midbrain DA Neurons
The effects of AMPH on endogenous EAAT3 carriers were
examined in ventral tegmental area (VTA) DA neurons in adult
midbrain slices. VTA DA neurons could be readily identified by
robust DAT immunolabeling and all DAT(+) cells were colabeled
with EAAT3 (Figure 2A). Similar colocalization was observed in
the SN (Figure S2A). Additional EAAT3(+)/TH() cells were also
evident. Processes projecting away from the VTA to the cortex
and nucleus accumbens were also DAT(+) and EAAT3(+) sug-
gesting that the two carriers colocalize in neuronal soma and
processes. To assess internalization of endogenous EAAT3,
brain slices were exposed to vehicle or AMPH for 30 min atNeuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc. 405
Figure 2. Endogenous EAAT3 in DA Neurons
in Brain Slices Also Internalize in Response
to AMPH
(A) DA neurons in midbrain slices express EAAT3.
Midbrain sections were immunolabeled for DAT
(green) and EAAT3. Soma of DAT(+) neurons in the
midbrain were also EAAT3 (top). Further out at the
processes, these two transporters are still found in
the same cells (bottom).
(B) Biotinylated EAAT3 from acute midbrain slices
decreases in response to AMPH. Acute midbrain
slices from adult mice were exposed to AMPH,
cocaine, or AMPH and cocaine together. All mem-
brane proteins were biotinylated and analyzed by
SDS-Page gel. Probing for EAAT3 indicates a loss of
membrane accessible protein in response to AMPH
that is prevented by cocaine. DAT protein demon-
strates the same sensitivity.
(C) Quantification of changes in membrane expres-
sion of DAT and EAAT3. Densitometry of EAAT3 and
DAT shows significant internalization of both carriers
that is blocked by cocaine. *p < 0.05 and ***p < 0.001
by two-way ANOVA. All data represent mean ± SEM.
(D) Quantification of changes in membrane expres-
sion of several membrane proteins in response
to AMPH. Glutamate receptor subunits GluR1,
GluR4, and NR1 remain at the cell membrane
following exposure to AMPH. The glutamate trans-
porter EAAT2 is also not mobilized by AMPH. EAAT3
and DAT data are the same samples shown in (C).
*p < 0.05 by paired t tests for each protein.
See also Figure S2.
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Amphetamine-Mediated Internalization of EAAT337 in ACSF. Surface proteins were biotinylated with a cell-
impermeable biotin reagent, isolated with NeutrAvidin beads,
separated on an SDS gel, and probed with an antibody to
EAAT3. AMPH pretreatment significantly decreased biotinylated
EAAT3 in lysates of acute slices (Figures 2B and 2C), consistent
with a reduction in EAAT3 at the cell surface. We found these re-
sults to be consistent across midbrain tissues from both male
and female animals (Figure S2B). The DAT antagonist, cocaine,
prevented the effects of AMPH on both EAAT3 and DAT,
whereas cocaine alone had no effect on membrane localization
of either protein. AMPH pretreatment decreased biotinylated
EAAT3 and DAT, but it did not affect astrocytic EAAT2 or the
glutamate receptor subunits NR1, GluR1, and GluR4 (Figure 2D).
We also found that peripheral injection of AMPH led to a signif-
icant loss of biotin-accessible EAAT3 in midbrain tissue (Fig-
ure S2C), thus establishing that these events occur in vivo. We
also assessed EAAT3 membrane localization in slices rostral
to the midbrain and found that in this area, which is devoid of
DAT(+) cell bodies but contains DAT(+)/EAAT3(+) processes
(Figure 2A), AMPH still reduces surface EAAT3 (Figure S2C).
Taken together, these data suggest that AMPH stimulates inter-
nalization of EAAT3 in brain tissues.406 Neuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc.AMPH-Mediated Internalization of
EAAT3 Depends on DAT
For AMPH-mediated internalization of the
DAT, AMPH must be present within the
cell (Kahlig et al., 2006). In acute brain slices,weobserved that cocaineblocksAMPH-mediated internalization
demonstrating a role for DAT in EAAT3 internalization (Figure 2C).
To directly test whether the DAT was required to initiate the
AMPH-mediated events that modulate EAAT3 activity, HEK293
cells were transfected with EAAT3 and DAT or with EAAT3 alone.
In these cells AMPH dose-dependently decreased glutamate
transport in cells expressing both DAT and EAAT3 (Figure 3A).
However, concentrations of AMPH up to 100 mM had no signifi-
cant effect on transport in the cells expressing EAAT3 alone.
The decrease in EAAT3-mediated 3H-glutamate transport in
EAAT3/DAT-expressing cells could be prevented by coapplica-
tion of the DAT inhibitor cocaine with the AMPH (Figure 3B).
Cocaine alone had no significant effect on EAAT3 transporters
in these cells. These results indicate that endocytosis of EAAT3
depends on the transport of AMPH into the cell by the DAT.
To further examine the role of DAT in the action of AMPH
on EAAT3, we engineered a functional EAAT3 chimera with a
biotin acceptor peptide (AP, GLNDIFEAQKIEWHEAR) inserted
in extracellular loop 2 of EAAT2. The AP peptide sequence is
recognized and biotinylated specifically by the E. coli enzyme
BirA (Howarth and Ting, 2008). We designed a dual expression
vector with the eGFP-EAAT3-AP chimera at one site and the
Figure 3. EAAT3 Sensitivity to AMPH De-
pends on DAT Coexpression
(A) Glutamate transport in HEK293 cells express-
ing EAAT3 or EAAT3 and DAT HEK293 cells were
transiently transfected with either EAAT3 or EAAT3
and DAT and exposed to increasing concentra-
tions of AMPH. 3H-glutamate uptake was then
measured. Glutamate transport in cells expressing
only EAAT3 did not respond to AMPH pretreat-
ment while those expressing both DAT and EAAT3
exhibited a decrease in transport capacity. All data
represent mean ± SEM.
(B) Pharmacology of AMPH-mediated decrease
in EAAT3 activity HEK293 cells expressing only
EAAT3 were unaffected by AMPH but gluta-
mate transport was greatly decreased in cells
expressing both EAAT3 and DAT. Cocaine
(100 mM) coapplication was sufficient to block
AMPH-mediated effects on these cells but had
no effect on its own. ***p < 0.001 by one-way
ANOVA.
(C) Membrane labeling of eGFP-EAAT3-AP in
primary neurons. Primary neurons were tran-
siently transfected with eGFP-EAAT3-AP con-
structs, treated with vehicle or AMPH for 30 min,
and then labeled for surface localized transporter.
Total protein (green, GFP) did not differ from
vehicle-treated control, however, the proportion
of carrier that could be labeled at the mem-
brane (red, Streptavidin-Alexa Fluor 568) greatly
decreased in response to AMPH.
(D) Quantification of membrane-labeled GFP-EAAT3-AP in DAT(+) and DAT() neurons. Membrane and total (green) expression in both DAT(+) and DAT()
primary neurons in culture were quantized by photon counting. Data are expressed as a ratio of membrane fraction to total. **p < 0.01 by one-way ANOVA. Scale
bars represent 50 mm.
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Amphetamine-Mediated Internalization of EAAT3BirA enzyme tagged with an ER-retention signal (KDEL) in a sec-
ond site, thus enabling the coexpression of BirA enzyme and
subsequent biotinylation of the eGFP-EAAT3-AP protein as it
transits through the ER. Addition of cell-impermeable streptavi-
din-Alexa-568 to HEK293 cells coexpressing eGFP-EAAT3-AP
and KDEL-BirA, efficiently labeled the eGFP-EAAT3-AP protein
at the cell surface with only a modest decrease in 3H-glutamate
uptake (<15%). AMPH treatment of HEK293 cells transiently ex-
pressing eGFP-EAAT3-AP and DAT significantly decreased
the Streptavidin-Alexa 568-labeled surface eGFP-EAAT3-AP
by 49% ± 6%, similar to results observed after biotinylation of
AMPH-treated brain slices (Figure 2B).
BecauseEAAT3 isbroadlyexpressed inneuronsand is not spe-
cific to DA neurons, we used the eGFP-EAAT3-AP labeling assay
to assess membrane localization of EAAT3 in DAT(+) and DAT()
neurons in culture. In DAT(+) primary neurons expressing eGFP-
EAAT3-AP, extracellular labeling of the glutamate transporter
was significantly attenuated (50.6% ± 5%) in AMPH-treated cul-
tures compared to those treated with vehicle alone (Figures 3C
and 3D). In contrast, DAT() displayed no response to AMPH.
These data indicate that the actions of AMPH on EAAT3 in neu-
rons depend on DAT, similar to observations in HEK293 cells.
The Mechanism of AMPH-Mediated EAAT3
Internalization
To confirm that the observed changes in cellular distribution of
EAAT3 were due to an increase in the rate of internalization ofeGFP-hEAAT3-AP and not to a decrease in rate of insertion at
the membrane, we used a pH-sensitive dye, CypHer5, coupled
to streptavidin to monitor internalization. CypHer5 fluoresces
maximally at infrared wavelengths under acidic conditions
and is ideally suited for monitoring surface protein internaliza-
tion into acidic endosomal compartments (Adie et al., 2003).
CypHer5 streptavidin binds to the biotin-tagged eGFP-
hEAAT3-AP at the surface and fluoresces only after it is internal-
ized and enters an acidic compartment. Using this method to
monitor internalization, we observed that AMPH application re-
sulted in a significant increase in intracellular CypHer5 labeling
within 10 min when compared to vehicle-treated controls
(Figures 4A and 4B). These data indicate that biotinylated
eGFP-hEAAT3-AP labeled at the cell surface with the CypHer5-
Streptavidin internalized and appears in cytosolic compartments
in response to AMPH. Similar results were observed with AP-
tagged DAT following exposure to AMPH (Figures S3A and S3B).
We next sought to define the endocytic mechanism for EAAT3
internalization. Dynamin is a GTPase that plays a prominent role
in multiple types of endocytosis (for review, see Mayor and
Pagano, 2007). Dynasore, a cell-permeable inhibitor of dynamin
reduced the AMPH-mediated decrease in glutamate uptake in
HEK293 cells transfected with both EAAT3 and DAT demon-
strating that the process is dynamin-dependent (Figure 4C).
Several dynamin-dependent endocytic pathways can mediate
the internalization of plasma membrane proteins; one pathway,
which is clathrin-independent, depends on the activation of theNeuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc. 407
Figure 4. Mechanism of AMPH-Mediated
EAAT3 Internalization
(A) AMPH stimulated movement of CypHer5-
labled EAAT3 protein into intracellular vesicles.
HEK293 were transiently transfected with DAT
and eGFP-EAAT3-AP. The uniquely biotinylated
eGFP-EAAT3-AP was labeled with streptavidin
conjugated to the pH-sensitive dye, CypHer5.
Over 10 min under vehicle conditions, cells did not
exhibit robust CypHer5 labeling. However, 10 min
of AMPH (10 mM) led to an increase in CypHer5
fluorescence.
(B) Quantification of CypHer-5 labeling at 10 min
following vehicle or AMPH treatment. *p < 0.05 by
paired t test. All data represent mean ± SEM.
(C) AMPH-induced EAAT3 internalization is dyna-
min-mediated. The AMPH-induced decrease in
3H-glutamate uptake in HEK293 cells expressing
DAT and EAAT3 was prevented by coapplication
of the dynamin inhibitor Dynasore.
(D) EAAT3 internalization by AMPH is RhoA-
mediated. Cotransfection of EAAT3 and DAT with
wild-type RhoA did not alter EAAT3 sensitivity to
AMPH. However, coexpression of the dominant
negative T17N attenuated EAAT3 AMPH-mediated endocytosis. The constitutively active mutant, V14, also exhibited a diminished effect of AMPH pretreatment
on 3H-glutamate uptake, however, the baseline transporter capacity of these cells was significantly diminished initially under vehicle control conditions.
(E) Coexpression of the exotoxin, C3, also blocked AMPH sensitivity in these cells. *p < 0.05, ***p < 0.001, and ****p < 0.0001 by one-way ANOVA.
See also Figure S3.
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Amphetamine-Mediated Internalization of EAAT3small GTPase, RhoA. To address whether RhoA activation was
required we examined the effects of inhibiting or enhancing
RhoA activity on AMPH-induced EAAT3 internalization. In
HEK293 cells coexpressing EAAT3 and DAT, AMPH-mediated
EAAT3 internalization was inhibited by expression of either the
clostridial exotoxin C3, a selective Rho inhibitor (Figure 4D) or
thedominantnegativemutant,RhoA-T17N (Figure4E). Incontrast,
as shown in Figure S3C, a dominant negative version of Rac1,
another small GTPase, does not block the AMPH-induced endo-
cytosis of EAAT3. Cells expressing a constitutively active mutant,
RhoA-V14 (Figure 4E) had no response to AMPH, but the baseline
3H-glutamate uptake was greatly decreased (43% ± 5.05%)
indicating that constitutive activation of RhoA alone decreases
EAAT3 surface expression and precludes further downregulation
by AMPH. Taken together, the results of these studies indicate
that AMPH-mediated internalization of EAAT3 proceeds through
a RhoA-dependent, dynamin-dependent mechanism.
A Unique Sequence in the C Terminus of EAAT3 Is
Important for Sensitivity to AMPH
AMPH appears to act selectively on trafficking of EAAT3, but not
EAAT1 or EAAT2, suggesting the presence of a distinct motif in
EAAT3 that confers sensitivity to AMPH. We initially focused on
the cytoplasmic C terminus of EAAT3 to identify a potential signal
sequence for AMPH sensitivity of EAAT3. Because EAAT2 local-
ization and transport is insensitive to AMPH, we engineered chi-
meras in which varying lengths of the C terminus of EAAT3 were
added to the full-length EAAT2 protein (Cheng et al., 2002) and
assessed the ability of these constructs to transport glutamate.
Chimeras that included the entire cytoplasmic C terminus of
EAAT3, E2+E3 (469–525) or a shorter segment of the C terminus,
E2+E3 (498–525) displayed a decrease in glutamate transport408 Neuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc.after AMPH treatment (Table 1). However, a construct with a
smaller segment of the C terminus, E2+E3 (511–525) was not
sensitive to AMPH. All three chimeras displayed baseline trans-
port of 3H-glutamate comparable to that of the parent EAAT2
(Table S1) and showed normal surface expression as assessed
by confocal microscopy, indicating that the results are not an
artifact of variations in expression. These data suggest that a
unique sequence between residues 498 and 511 of EAAT3 con-
fers its sensitivity to AMPH.
To further resolve the motif required for the actions of AMPH
on EAAT3, we examined the effect of a series of pairs of alanine
substitutions (504–505, 506–507, and 508–509) on internalization
(Table 1). Each pair of substitutions attenuated the sensitivity
of the E2+E3 (498–525) chimera to AMPH suggesting a role for
this entire domain in EAAT3 sensitivity to AMPH. An E2+E3
chimera containing a single amino acid substitution mutant
E2+E3 (A509S) retained sensitivity to AMPH and thus further
delineated the motif to the sequence VNGGF. A tyrosine-based
motif (YVN) at 503–506 in EAAT3 has been implicated in constitu-
tive, clathrin-mediated endocytosis of the carrier (D’Amico et al.,
2010). We examined the Y503A mutation in the E2+E3 chimera
and found that it still internalized in response to AMPH suggest-
ing that constitutive clathrin-dependent cycling is not directly
involved in AMPH-mediated EAAT3 internalization. Alanine sub-
stitution of residues 504–508 in the wild-type EAAT3 (E3 (504–
508A5) eliminated theAMPH response (Table 1), further resolving
the motif to the region comprised of the sequence VNGGF.
A Cell Permeable Peptide Including the C-Terminal
Motif Occludes AMPH-Induced Trafficking of EAAT3
To further examine the role of the VNGGF peptide in AMPH-
mediated internalization of EAAT3, we designed a TAT fusion
Table 1. Alanine Scanning of C Terminus of EAAT3 for Sensitivity to AMPH
Construct Sequence Glu Uptake after AMPH Treatment (SEM)
EAAT3 – – DTKKSYVNGGFAVDKSDTISFTQTSQF 52.80% (8.42)a
EAAT2 – – DECKVTLAANGKSADCSVEEEPWKREK 94.17% (7.50)
E2+E3 (469–525) EAAT2..EK AGSA ELEQMDVSSEV...GGFAVDKSDTISFTQTSQF 49.46% (10.74)c
E2+E3 (498–525) EAAT2..EK AGSA DTKKSYVNGGFAVDKSDTISFTQTSQF 49.44% (12.07)b
E2+E3 (511–525) EAAT2..EK AGSA VDKSDTISFTQTSQF 93.91% (7.80)
E2+E3 (Y503A) EAAT2..EK AGSA DTKKSAVNGGFAVDKSDTISFTQTSQF 57.85% (3.95)a
E2+E3 (504–5 AA) EAAT2..EK AGSA DTKKSYAAGGFAVDKSDTISFTQTSQF 81.21% (4.12)
E2+E3 (506–507 AA) EAAT2..EK AGSA DTKKSYVNAAFAVDKSDTISFTQTSQF 94.93% (2.65)
E2+E3 (508–509 AA) EAAT2..EK AGSA DTKKSYVNGGAAVDKSDTISFTQTSQF 101.02% (8.37)
E2+E3 (A509S) EAAT2..EK AGSA DTKKSYVNGGFSVDKSDTISFTQTSQF 42.83% (3.18)c
E2+E3 (304–308 A5) EAAT2..EK AGSA DTKKSYAAAAAAVDKSDTISFTQTSQF 91.70% (3.16)
EAAT3 (504–508 A5) EAAT3 – DTKKSYAAAAAAVDKSDTISFTQTSQF 96.32% (7.06)
See also Table S1.
ap < 0.01 by one-way ANOVA compared to vehicle-treated control
bp < 0.001 by one-way ANOVA compared to vehicle-treated control
cp < 0.001 by one-way ANOVA compared to vehicle-treated control
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Amphetamine-Mediated Internalization of EAAT3peptide containing this sequence (Figure 5A). The TAT domain
facilitates entry of peptides into cells, and we hypothesized
that the introduction of an excess of the TAT-EAAT3 fusion pep-
tide could compete with the endogenous EAAT3 motif and inter-
fere with the formation of AMPH-induced regulatory complexes.
HEK293 cells were transiently transfected with EAAT3 and DAT
and treated with either the TAT-EAAT3 (504–509, VNGGFA)
sequence or a TAT-peptide with a scrambled version of the
sequence (TAT-scrambled, GVNAGF) for 30 min and then
treated with AMPH or vehicle for 30 min. Addition of the TAT-
EAAT3 peptide had no effect on baseline 3H-glutamate uptake,
but blocked the ability of AMPH to decrease transport activity
(Figure 5B). The scrambled TAT peptide had no effect on gluta-
mate uptake or on the AMPH-induced decrease in transport.
To confirm that the TAT-EAAT3 peptide was altering AMPH-
induced trafficking of EAAT3, we cotransfected HEK293
cells with the eGFP-EAAT3-AP construct and DAT. Assays of
EAAT3 surface expression using extracellular Streptavidin-
Alexa568 labeling demonstrated that the TAT-EAAT3 peptide
could prevent AMPH-induced endocytosis (Figures 5C and
5D). The TAT-scrambled peptide had no effect on AMPH-
mediated internalization of the eGFP-EAAT3-AP protein. Parallel
assays performedwith a DAT-AP construct revealed that AMPH-
induced DAT internalization was not affected by coapplication of
either the TAT-EAAT3 or TAT-scrambled peptide (Figure 5D,
inset).
The ability of the VNGGF motif to interfere with AMPH-medi-
ated trafficking of the endogenous EAAT3 was also examined
in acute midbrain slices from adult mice. Using cell surface bio-
tinylation of slices to assess changes in EAAT3, we observed an
AMPH-induced decrease in surface EAAT3 in tissue incubated
with the TAT-scrambled peptide (comparable to the AMPH ef-
fect in slices shown in Figure 2C). In contrast, the TAT-EAAT3
peptide prevented AMPH-induced internalization of EAAT3 (Fig-
ures 5E and 5F). These effects appeared to be selective for
EAAT3 because AMPH-induced DAT internalization remainedrobust in these lysates (Figure 5F, inset). These data are similar
to observations in transfected HEK293 cells with the TAT pep-
tides where the EAAT3-specific peptide blocked EAAT3, but
had no effects on the membrane localization or function of DAT.
EAAT3 Internalization Mediated by AMPH Potentiates
Synaptic Neurotransmission
Although endogenous EAAT3 appears to be internalized in
response to AMPH, it was unclear to what extent the resulting
changes in glutamate clearance would alter excitatory signaling.
We assessed the effects of AMPH on evoked glutamatergic
synaptic currents (eEPSCs) in DA neurons within the substantia
nigra using whole-cell patch-clamp recordings. To resolve the
selective effects of AMPH on excitatory signaling, experiments
were done in the presence of DA receptor blockers (see Exper-
imental Procedures). We found that AMPA receptor-mediated
eEPSCs were potentiated to 134% ± 6% (Figure 6A; n = 5)
and NMDA-mediated eEPSC amplitudes were increased by
150% ± 10% following superfusion of AMPH (10 mM; Figure 6B;
n = 6). DA neurons in the VTA also demonstrated an increase in
glutamatergic synaptic response following AMPH superfusion
(158% ± 20%). Preincubation of the slices with the selective
DAT inhibitor, GBR12909 (1 mM) blocked the AMPH-induced
increase in NMDA-mediated eEPSCs (Figure S4) suggesting
that DAT is necessary for the AMPH effect on these synaptic
currents.
The EAAT3 PeptideMotif Also Prevents the Potentiation
of Glutamatergic Synaptic Responses by AMPH
We next tested whether the selective EAAT3 inhibitor peptide
could block the AMPH-mediated increase in synaptic re-
sponses (Figures 6D and 6E). The scrambled peptide (GVNAGF)
or the EAAT3 inhibitor peptide (EAAT3 [504–509, VNGGFA]) were
added to the whole-cell pipette solution and allowed to perfuse
into the neurons through the patch-clamp electrode for 15 min
prior to eliciting stable baseline synaptic currents. AMPHNeuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc. 409
Figure 5. Introduction of the EAAT3 C-Ter-
minal Motif Disrupts the Effect of AMPH on
EAAT3
(A) Schematic of TAT-peptide constructs.
(B) Responses to AMPH in HEK293 cells exposed
to TAT-EAAT3. HEK293 cells transfected with DAT
and EAAT3 were assessed for EAAT3 activity
by 3H-glutamate uptake. Cells treated with TAT-
scrambled were still sensitive to AMPH, but TAT-
EAAT3 abolished the AMPH-mediated decrease
in carrier activity.
(C and D) EAAT3 internalization is blocked
by TAT-EAAT3 in HEK293 cells. (C) HEK293
cells were transiently transfected with DAT
and eGFP-EAAT3-AP, treated with TAT-EAAT3
(top) or TAT-scrambled (bottom) and then
AMPH. Total eGFP-EAAT3-AP expression was
not altered (green), but the surface localized
transporters labeled with streptavidin-Alexa 568
were decreased only in cells exposed to the TAT-
scrambled peptide. TAT-EAAT3-treated cells still
had robust surface localized eGFP-EAAT3-AP.
(D) Quantification of vehicle-treated TAT-EAAT3
or TAT-scrambled eGFP-EAAT3-AP membrane
localization demonstrates no baseline effect on
the transporter. The response to AMPH, however,
is blocked in cells treated with TAT-EAAT3 only.
Inset: in parallel assays, DAT membrane expres-
sion is decreased in response to AMPH with
both the scrambled as well as the EAAT3 TAT
peptides.
(E) Biotinylation of endogenous EAAT3 in an
acute brain slice. Western blot of biotinylated
EAAT3 in acute brain slices treated with TAT-E3
(top) or TAT-scrambled (bottom) demonstrate
EAAT3 trafficking induced by AMPH in the
TAT-scrambled-treated slices only. TAT-EAAT3
abolished the AMPH-mediated internalization of
EAAT3.
(F) Quantification of biotinylated EAAT3 in acute brain slices. Inset: DAT membrane expression is decreased in response to AMPH under both conditions. Scale
bar represents 25 mm for merged images, 50 mm for single color images. *p < 0.05 by one-way ANOVA. All data represent mean ± SEM.
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Amphetamine-Mediated Internalization of EAAT3produced an increase in the synaptic-mediated currents in the
presence of the scrambled peptide (n = 4) but this effect was
blocked in cells pretreated with the EAAT3 inhibitor peptide
(n = 7). The EAAT3 interfering peptide also blocked glutamatergic
synaptic potentiation in DA neurons in the VTA. These data
directly implicate EAAT3 in the potentiation of glutamatergic
signaling by AMPH in midbrain DA neurons.
Pharmacological Inhibition of EAAT3 in DA Neurons
Mimics the Effects of AMPH
DL-threo-b-benzyloxyaspartic acid (TBOA) is a nontransported
inhibitor of EAATs that can block the carriers from the inside
(Watzke and Grewer, 2001). We used this inhibitor or the vehicle
(DMSO) in the intracellular pipette solution to determine if selec-
tive blockade of EAAT3 in the recorded neuron was sufficient
to potentiate eEPSCs. Intracellular DMSO did not alter eEPSCs
and superfusion of AMPH significantly increased eEPSCs
from 168 ± 14 to 307 ± 15 pA (n = 8; Figures 7A and 7C),
similar to previous observations (Figure 6). Administration of
intracellular TBOA (200 mM) during whole-cell recordings slowly
increased basal eEPSCs from165 ± 12 pA to228 ± 28 pA and410 Neuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc.occluded the effect of AMPH (224 ± 42 pA; n = 10; Figures 7B
and 7C). There is not a statistically significant difference between
TBOA- and AMPH-treated eEPSCs. These data indicate that
blockade of EAAT3 activity is sufficient to alter eEPSCs, similar
to treatment with AMPH.
DISCUSSION
We report here that AMPH potentiates the action of glutamate
on DA neurons through amechanism involving RhoA-dependent
endocytosis of the neuronal glutamate transporter, EAAT3. We
demonstrate that this AMPH-induced internalization of EAAT3
is of sufficient magnitude to enhance glutamatergic responses
in DA neurons. DA neurons receive glutamatergic inputs from
several sources including the globus pallidus, subthalamic
nucleus, striatum, amygdala, thalamus, hypothalamus, superior
colliculus, reticular formation, and the periaqueductal gray, indi-
cating multiple distinct circuits that could be significantly
affected by internalization of EAAT3 in DA neurons.
Although DA neurons are characterized by their ability to syn-
thesize, package, and release DA, several recent studies have
Figure 6. AMPH Potentiates Glutamatergic
Synaptic Transmission
(A) Averaged AMPA-mediated evoked excitatory
postsynaptic currents (eEPSCs) are increased
following AMPH (10 mM) superfusion.
(B) Averaged NMDA-mediated eEPSCs are also
potentiated by AMPH.
(C) Bar graphs with compiled data for AMPA- and
NMDA-mediated eEPSCs in control and in the
presence of AMPH (10 mM).
(D) The effect of AMPH on AMPA-mediated
eIPSCs was abolished with the EAAT3 peptide in
the intracellular solution compared to a scrambled
peptide.
(E) Bar graph showing the AMPH-induced poten-
tiation normalized to baseline AMPA-mediated
eIPSCs. *p < 0.05 by Student’s t test. All data
represent mean ± SEM.
See also Figure S4.
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transporters, vGLUT2, which allow glutamate to be packaged
in synaptic vesicles and released during neurotransmission
(Hnasko et al., 2012; Kawano et al., 2006; Stuber et al., 2010;
Trudeau, 2004). In fact, vGLUT2-mediated glutamate release
from DA neurons has been found to be essential to AMPH-medi-
ated behavioral responses (Birgner et al., 2010). Elevations in
extracellular glutamate concentrations after AMPH treatment
have been observed in the striatum (Del Arco et al., 1999;
Mora and Porras, 1993), nucleus accumbens (Dalia et al.,
1998; Xue et al., 1996), and prefrontal cortex (Del Arco et al.,
1998) supporting a role for AMPH-mediated EAAT3 modulation
at postsynaptic targets of DA and glutamate release from dopa-
minergic neurons. Indeed, our biotinylation data addressing
EAAT3(+) processes in slices more rostral to the midbrain sug-
gests that AMPH-mediated endocytosis also occurs in terminal
fields of DA projections (Figure S2C).
Relationship between AMPH-Mediated Internalization
of EAAT3 and the DAT
AMPH-mediated internalization of EAAT3 depends upon DAT
coexpression. Primary midbrain neurons that did not express
DAT showed no downregulation of EAAT3 after AMPH treat-
ment, whereas DAT(+) neurons in the same culture displayed
robust AMPH-mediated internalization of EAAT3. Although there
could be other proteins expressed by DAT(+) neurons that
contribute to AMPH-mediated trafficking changes in EAAT3,
additional data underscore the importance of the DAT for this ef-
fect. For example, in transiently transfected HEK293 cells, which
neither synthesize nor release DA, AMPH-induced EAAT3 inter-
nalization exhibits the same dependence upon DAT. Previous
work has shown that AMPH also stimulates internalization of
the DAT itself through a mechanism that is dependent upon
AMPH transport through the carrier and into the cytosol (Kahlig
et al., 2006). As was observed for AMPH-induced DAT traf-
ficking, the effects of AMPH on EAAT3 internalization wereblocked by cocaine, consistent with the idea that AMPH acts
intracellularly after entry through DAT. Moreover, we also found
that the DAT-specific antagonist GBR12909 blocked the ability
of AMPH to potentiate synaptic responses. Notably, AMPH ac-
tions on EAAT3 do not depend on increases in DA or DA receptor
activation, because they occur even in the absence of DA
synthesis and in the presence of DA receptor blockers. Taken
together, these data indicate that the actions of AMPH within
the cell not only enhance DA signaling by blocking DA uptake
and increasing release, but also directly affect glutamatergic
neurotransmission by prolonging the action of glutamate
released from or onto DA neurons.
The dependence of EAAT3 internalization on the DAT also
suggests that the two transporters might be internalized
together. We found that EAAT3 and DAT are expressed in the
same cells, as well as in axons and dendrites. However, the sub-
cellular colocalization of the two neurotransmitter transporters
remains to be established definitively by high resolution electron
microscopy. One intriguing finding is that the C-terminal peptide
motif in EAAT3 that interferes with AMPH-induced EAAT3 inter-
nalization did not affect DAT internalization (Figure 5). Moreover,
efforts to coimmunoprecipitate EAAT3 and DAT under control
or AMPH-stimulated conditions produced negative results and
imply that they may not be physically linked. However, these re-
sults do not rule out the possibility that AMPH regulates the two
carriers in a coordinated fashion. One intriguing possibility is
that they may both be associated with the same AMPH-sensi-
tive, macromolecular regulatory machinery, but interact with
this complex through different sites.
Endocytic Mechanism Involved in EAAT3 Internalization
by AMPH
We propose that internalization of EAAT3 by AMPH proceeds
by a specialized clathrin-independent and dynamin-mediated
internalization pathway that requires the activation of the small
GTPase, RhoA (Figure 4). There are three subfamilies of RhoNeuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc. 411
Figure 7. AMPHModulation of EAAT3 Is Involved in the Potentiation
of NMDA EPSCs by AMPH
(A) Amplitudes of NMDA-mediated EPSCs (every 30 s) were measured over
time after breaking into whole-cell mode (t = 0 min) with pipette solutions
containing vehicle (DMSO) control (n = 8). AMPH was superfused during the
time denoted by bar.
(B) Time course after breaking into whole-cell mode (t = 0 min) with pipette
solutions containing TBOA (200 mM; n = 10).
(C) Bar graph showing the changes in eEPSC amplitude with either vehicle
(DMSO) or TBOA added to the intracellular recording solution (two-way
repeated-measures ANOVA, F[2,16] = 8.548, p < 0.05). AMPH increased the
amplitude of NMDA eEPSCs in cells recorded with vehicle but had no effect in
cells recorded with intracellular TBOA. In those cells, TBOA alone significantly
increased eEPSCs (*p < 0.05). All data represent mean ± SEM.
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Amphetamine-Mediated Internalization of EAAT3proteins (Rho, Rac, and CDC42), which all play a major role as
regulators of actin cytoskeletal remodeling and this function
of Rho family GTPases likely plays an important role during412 Neuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc.RhoA-mediated endocytosis. Internalization of the interleukin-2
receptor has been characterized as clathrin-independent, dyna-
min-dependent, and mediated by RhoA activation (Lamaze
et al., 2001), and a number of observations support the idea
that AMPH-mediated effects on EAAT3 trafficking occur through
similar RhoA-mediated internalization processes. Experiments
using coexpression of a dominant negative RhoA construct or
a Rho-inhibiting exotoxin C3 confirm the dependence on acti-
vated RhoA. In addition, as noted for other RhoA-dependent
endocytic processes, the effects of AMPH on EAAT3 surface
expression are blocked by inhibition of dynamin activity.
The mechanism by which AMPH activates RhoA-dependent
internalization remains unclear, although RhoA can be activated
through several pathways, a few of which are particularly
intriguing candidates for mediating the intracellular effects of
AMPH. RhoA-mediated changes in dendritic spine morphology
are initiated by an influx of calcium through NMDA receptors
and subsequent activation of calmodulin/CamKII (Murakoshi
et al., 2011). AMPH also increases intracellular calcium (Gnegy
et al., 2004) that is associated with calmodulin/CamKII activation
(Wei et al., 2007) and modulation and trafficking of the DAT (Fog
et al., 2006; Sakrikar et al., 2012). G12/13-coupled G protein
coupled receptors (GPCRs) can also activate RhoA (Buhl et al.,
1995) and AMPH may stimulate an intracellular GPCR found
in DA neurons. The process of RhoA activation by AMPH that
leads to EAAT3 internalization may parallel one or more of these
previously described pathways.
A C-Terminal Peptide, VNGGF, Interferes with
AMPH-Induced EAAT3 Endocytosis
The identification of a small peptide segment, VNGGF, in the
EAAT3 cytosolic C terminus required for EAAT3 sensitivity to
AMPH was the basis for generating a cell-permeant fusion pro-
tein that interferes with EAAT3 internalization. This provided a
selective tool to explore the effects of AMPH on EAAT3 mem-
brane localization and on excitatory neurotransmission in brain
slices. We hypothesize that this sequence in the C terminus of
EAAT3 is either a direct recognition signal for AMPH-induced
RhoA-dependent endocytosis or that it facilitates interaction
with anchoring machinery that can be disrupted by the signaling
mechanisms that are activatedwhen AMPH enters the cell. Inter-
estingly, this sequence overlaps a motif that was previously
shown to be required for the polarized sorting of EAAT3 to the
apical membrane of polarized MDCK cells and to dendrites of
hippocampal neurons (Cheng et al., 2002). How, or if, polariza-
tion and AMPH sensitivity are related is unclear. We did not
observe a clearly polarized localization of EAAT3 in midbrain
TH(+) neurons suggesting distinct roles for this sequence in
hippocampal neurons and DA neurons. The binding partners of
this sequence, VNGGF, have not been identified and further
investigation will reveal additional proteins essential for traf-
ficking of EAAT3.
Modulation of Glutamatergic Synaptic Responses
We observed potentiated AMPA- and NMDA-mediated evoked
synaptic currents in the presence of AMPH. This could be due
to either enhanced glutamate release or reduced glutamate up-
take. Incorporation of the specific EAAT3 peptide that prevented
Neuron
Amphetamine-Mediated Internalization of EAAT3EAAT3 internalization into the intracellular pipette solution
blocked the AMPH-mediated potentiation of glutamatergic cur-
rents. These results indicate thatmodulatory actions of AMPHon
AMPA and NMDA receptors are postsynaptic. Because both
AMPA and NMDA receptor responses are potentiated, the
simplest explanation would be that extracellular glutamate con-
centrations increase with AMPH. However, the relatively slow
transport kinetics of EAAT3 suggest that EAAT3 has a modest,
if any, direct role for EAAT3 in shaping acute synaptic responses
(Diamond and Jahr, 1997). The perisynaptic localization of
EAAT3 (Danbolt, 2001) may facilitate regulation of glutamate
concentrations that activate extrasynaptic glutamate receptors
indicating that AMPH-induced EAAT3 internalization could
potentiate synaptic glutamatergic responses by regulating gluta-
mate spillover. To date, these studies examining the physiolog-
ical influence of EAAT3 on glutamate signaling have emphasized
major glutamatergic neuronal groups and pathways. Our work
examines how postsynaptic modulation of EAAT3 activity might
shape the signal from excitatory inputs onto DA neurons, which
have highly unique structural and physiological properties.
Another potential mechanismbywhich AMPH-induced EAAT3
internalization could alter glutamatergic synaptic responses is
through changes in trafficking and surface localization of gluta-
mate receptors (Mao et al., 2011), similar to the adaptations
in AMPA and NMDA receptor surface distribution seen with
cocaine administration and withdrawal (Brown et al., 2011; Gha-
semzadeh et al., 2009; Schumann and Yaka, 2009). We did not
detect a change in membrane expression of AMPA subunits
GluR1 or GluR2 or the NMDA subunit NR1 with biotinylation as-
says, consistent with prior reports (Nelson et al., 2009). However,
the number of receptors that would be needed to potentiate syn-
aptic responses may be below the level of detection of a bio-
tinylation assay. Modulation of glutamate receptors may also
be a function of lateral movement of receptors from perisynaptic
sites into the synapse or functional modifications, such as phos-
phorylation. Nevertheless, the specificity of the interfering
peptide for EAAT3 internalization and the ability of the blocking
peptide to inhibit the AMPH-mediated increase in glutamatergic
synaptic currents strongly implicates internalization of EAAT3
as paramount to any subsequent AMPH-evoked events in
increasing synaptic activity.
AMPH-Mediated Internalization of EAAT3MayModulate
DA Neuron Firing Patterns
Several studies describe AMPH-mediated increases in DA
neuron firing that are, similar to EAAT3 trafficking, dependent
upon DAT expression. There are several mechanisms by which
AMPH modulates phasic firing rates of DA neurons including
activation of autoreceptors on DA neurons, activation of local
interneurons with reciprocal connections onto DA neurons, as
well as DAT-mediated conductances that are stimulated by
AMPH (Branch and Beckstead, 2012; Ingram et al., 2002). Glu-
tamatergic afferents are critical for the shift from tonic to phasic
firing in DA neurons and, intriguingly, in vivo studies demon-
strate that inactivation of the laterodorsal tegmentum, a gluta-
matergic afferent to VTA DA neurons, blocks burst firing (Lodge
and Grace, 2006). We predict that AMPH-mediated EAAT3
internalization and glutamatergic synaptic potentiation wouldcontribute to AMPH-induced modulation of phasic firing in DA
neurons.
Glutamate Plays aRole in Acute andAddictiveBehaviors
Associated with AMPH
AMPH administration increases extracellular glutamate concen-
trations that are associated with the development of behavioral
sensitization (Ferrario et al., 2011; Zhang et al., 2001). Both
AMPA and NMDA receptor inhibitors have been shown to
decrease AMPH-induced locomotor sensitization (Karler et al.,
1989; Vezina and Queen, 2000; Wolf and Khansa, 1991) and
self-administration (Karler et al., 1989; Suto et al., 2003; Vezina
and Queen, 2000; Wolf and Khansa, 1991) suggesting that acti-
vation of glutamate receptors is necessary for the behavioral
effects of AMPH. Modulation of glutamate neurotransmission
has been clearly linked to the actions of AMPH; however, these
actions have previously been thought to be indirect through the
actions of DA to shape activity within the limbic circuitry. Here,
we present evidence that AMPH can directly modulate not only
dopaminergic, but also glutamatergic signaling. Beyond the
more widely appreciated effects of AMPH to potentiate biogenic
amine signaling, we show here a distinct action of AMPH to in-
crease the internalization of EAAT3 and potentiate glutamatergic
synaptic activity in midbrain DA neurons. This dual action of
AMPH predicts that EAAT3 downregulation will underlie some
of the behavioral effects of AMPH and is consistent with previous
findings implicating glutamate transporters in AMPH-mediated
behaviors. For example, sensitization to AMPH is enhanced by
blocking glutamate transporters (Aked et al., 2005) while acute
responses (Rasmussen et al., 2011) and reinforcing effects (Fujio
et al., 2005; Rawls et al., 2010) of AMPH are attenuated
by increasing the expression of glutamate transporters. These
data underscore the importance of glutamate transporters




HEK293 cells (ATCC) were maintained in DMEM with 5% FBS and Pen/Strep.
Cells were transiently transfected with TransIt-LT1 transfection reagent
(Mirus). All cell culture assays were performed on cultures from at least three
different plating procedures. Where possible, experiments were performed
in a blind fashion.
Primary Midbrain Cultures
All animal-related protocols were approved by the University of Pittsburgh,
Oregon Health Sciences University Institutional Animal Care and Use Commit-
tees (IACUCs) or the National Institute of Mental Health Animal Care and Use
Committee (NIMH ACUC). Primary cultures were derived from midbrains of
E15 Swiss Webster mice. Tissue was dissociated and plated at a density of
three midbrains per 6 3 25 mm or 12 3 12 mm poly-D-lysine coated glass
coverslips (Warner Instruments). Cultures were treated with AraC to inhibit
astrocyte overgrowth and maintained in DMEM supplemented with 5% horse
serum and 5% calf serum for 2–4 weeks. Neurons were transiently transfected
with NeuroMag according to manufacturers instructions (Oz Biosciences).
3H-Glutamate Uptake Assays
Pretreatments with AMPH, cocaine, or TAT-fusion peptides were performed
in DMEM for 30 min at 37C in 5% CO2. Glutamate transport activity was
assessed with 250 mM cold glutamate and 100 nM 3H-glutamate in PBS withNeuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc. 413
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Amphetamine-Mediated Internalization of EAAT3100 mMCaCl2 and 1 mMMgCl2 for 10 min at room temperature. Cultures were
then washed with ice cold PBS, solubilized in scintillation fluid, and radioac-
tivity was measured by a 1250 Microbeta Wallac Liquid Scintillation Counter.
Background measurements were determined in cells treated similarly, but
not transfected with the transporter construct.
Acceptor Peptide Labeling
Cells were chilled to 4C to minimize further protein trafficking, nonspecific
binding was blocked with 5% milk in PBS and membrane proteins were
probed with Streptavidin conjugated to Alexa Fluor-568, washed with PBS,
and fixed with 4% paraformaldehyde.
Acute Substantia Nigra Slices
Male Swiss Webster mice were deeply anesthetized with isoflurane and
the brains were rapidly removed and placed in ice cold buffer containing
(in mM): 75 NaCl, 2.5 KCl, 0.1 CaCl2, 6 MgSO4, 1.2 NaH2PO4, 25 NaHCO3,
2.5 D-dextrose, 50 sucrose. Midbrain horizontal slices (1–230 mm) were cut
in 95% O2 and 5% CO2 oxygenated buffer and warmed to room temperature
in artificial cerebrospinal fluid (ACSF) containing kynurenic acid (50 mM) for at
least 30 min.
Electrophysiology
Patch clamp recordings were made from visually identified substantia nigra
pars compacta (SNc) neurons and further characterized by the presence of
a hyperpolarization-activated membrane rectification (Ih current) and post
hoc immunohistochemical staining for tyrosine hydroxylase (TH). Patch pi-
pettes had a resistance of 2–4 MOhm when filled with the intracellular solution
containing 130 mM CsCl, 5.4 mM KCl, 0.1 mM CaCl2, 2 mM MgCl2, 10 mM
HEPES, 1.1 mM EGTA, 30 mM D-dextrose, 2 mM MgATP, 0.3 mM NaGTP
[pH 7.3 Cells were voltage-clamped at –70 mV, currents were filtered at 2
kHz and digitized at 5 kHz (Multiclamp 700A, Molecular Devices). Synaptic
currents were evoked with bipolar stimulating electrodes placed 200–
300 mm distally from the recorded cell. Stimulation pulses were delivered
at 0.03 Hz and NMDA-mediated evoked excitatory postsynaptic currents
(eEPSCs) were recorded in Mg2+-free ACSF containing NBQX (5 mM) and
glycine (10 mM). AMPA-mediated eEPSCs were isolated in APV (50 mM), kynur-
enic acid (1 mM), and cyclothiazide (100 mM) to decrease maximal activation
by synaptic glutamate. Inhibitors of DA receptors and a-adrenergic were
included in the ACSF recording solution: DA-D1: SCH 23390, 1 mM; DA-D2:
raclopride 10 mM; a-AR: prazosin 1 mM. Bicuculline (10 mM) and strychnine
(1 mM) were also included in the bath to eliminate GABAA and glycine receptor
contamination. During each experiment, a voltage step of 10 mV from the
holding potential was applied periodically to monitor cell capacitance and
access resistance. Recordings in which access resistance or capacitance
changed by >10%during the experiment were excluded in data analysis. Elec-
trophysiology data were acquired and analyzed using AxoGraph X software
(Axograph).
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde, permeabilized with 1% Triton
X-100, blocked with 5% NGS or milk, and incubated in primary antibody at
1:1,000 overnight. Appropriate secondary Alexa Fluor conjugated antibodies
were applied at 1:10,000 for 1 hr, and coverslips were then mounted in
AntiFade (Invitrogen).
Antibodies
Primary antibodies used in this study were rabbit anti-EAAT3 (Alpha
Diagnostics), mouse anti-TH (Sigma), rat anti-DAT (Chemicon), rabbit
anti-EAAT3 (Alpha diagnostics), rabbit anti-EAAT2 (made in-house), rabbit
anti-GluR4 (Millipore), rabbit anti-GluR1 (Upstate), and mouse anti-NR1
(Millipore).
Microscopy
TIRF microscopy was done on an Olympus 1X71 equipped with a 603 TIRF
objective. Olympus Fluoview 1000 was used for confocal imaging and a Nikon
Diaphot200 was used for epifluorescent assays. Image analysis was per-
formed with Image J.414 Neuron 83, 404–416, July 16, 2014 ª2014 Elsevier Inc.Acute Midbrain Slices
For biochemical analysis, 1 mm midbrain slices from 6-week-old Swiss
Webster mice were prepared with a mouse brain slicer (Zivic). Slices rested
for 1 hr in ACSF containing kynurenic acid prior to each experiment. The
ACSF contained 126 mM NaCl, 3.5 mM KCl, 2 mM CaCl2, 1.3 mM MgCl2,
1.2 mM NaH2PO4, 25 mM NaHCO3, mM 10 D-dextrose [pH 7.4].
Biotinylation
Cell surface biotinylation was performed in ice cold buffer (in mM: 2 CaCl2, 150
NaCl, and 10 triethanolamine, pH 7.5) with 2 mg/ml sulfosuccinimidyl 2-
(biotinamido) methyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin; Pierce) for
20 min at 4C. Nonbound biotin was quenched for 20 min in glycine and prep-
arations were lysed in buffer comprised of 1% Triton X-100, 150 mM NaCl,
5 mM EDTA, and 50 mM Tris [pH 7.5], containing a protease inhibitor mixture
(Roche Molecular Biochemicals). Biotinylated proteins were isolated by a 2 hr
incubation with Ultralink immobilized NeutrAvidin beads washed with lysis
buffer, a high-salt wash buffer (0.1% Triton X-100, 500 mM NaCl, 5 mM
EDTA, and 50 mM Tris [pH 7.5]) and finally 50 mM Tris (pH 7.5).
Reagents
Peptides were ordered from Tien Life Sciences. AP and BirA constructs from
AddGene. All other reagents were from Sigma or Invitrogen.
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